Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,065 | 578 | 98.4% |
| Education | $116.97 | 10 | 1.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14.34 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,175 | 87 | $0 (2024) |
| Allergan, Inc. | $784.10 | 70 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $669.01 | 40 | $0 (2024) |
| Amgen Inc. | $523.54 | 37 | $0 (2024) |
| Novo Nordisk Inc | $405.81 | 35 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $388.49 | 27 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $385.50 | 29 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $361.77 | 22 | $0 (2023) |
| Corium, LLC | $311.70 | 20 | $0 (2024) |
| Merck Sharp & Dohme LLC | $291.98 | 22 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,181 | 68 | ABBVIE INC. ($374.05) |
| 2023 | $823.76 | 53 | AbbVie Inc. ($286.69) |
| 2022 | $733.43 | 53 | ABBVIE INC. ($187.88) |
| 2021 | $713.51 | 54 | AbbVie Inc. ($326.68) |
| 2020 | $421.09 | 36 | Allergan, Inc. ($133.52) |
| 2019 | $785.02 | 62 | PFIZER INC. ($116.10) |
| 2018 | $1,516 | 111 | Allergan Inc. ($212.01) |
| 2017 | $2,023 | 152 | Allergan Inc. ($326.11) |
All Payment Transactions
589 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.84 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $20.97 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 10/15/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.61 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.26 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Inflammation | ||||||
| 08/26/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: ADHD | ||||||
| 08/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.61 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/15/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.20 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Biological | ||||||
| 07/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Respiratory | ||||||
| 07/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: CNS Stimulant for ADHD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 806 | 1,586 | $98,253 | $58,519 |
| 2022 | 12 | 761 | 1,460 | $93,081 | $54,778 |
| 2021 | 12 | 740 | 1,682 | $91,522 | $52,669 |
| 2020 | 11 | 693 | 1,383 | $79,697 | $42,379 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 158 | 271 | $36,585 | $21,210 | 58.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 139 | 139 | $19,460 | $16,655 | 85.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 113 | 189 | $20,790 | $9,656 | 46.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 81 | 106 | $7,420 | $3,332 | 44.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 15 | 15 | $2,550 | $2,332 | 91.4% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 53 | 53 | $2,650 | $1,649 | 62.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 52 | 52 | $1,300 | $1,274 | 98.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 58 | 140 | $3,500 | $999.25 | 28.5% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 12 | 24 | $1,200 | $699.20 | 58.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 13 | 14 | $910.00 | $450.06 | 49.5% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 30 | 49 | $490.00 | $185.18 | 37.8% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 23 | 96 | $672.00 | $27.68 | 4.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 40 | 366 | $366.00 | $26.37 | 7.2% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 19 | 72 | $360.00 | $23.25 | 6.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 152 | 292 | $39,420 | $22,568 | 57.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 132 | 206 | $20,830 | $11,154 | 53.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 82 | 82 | $11,480 | $10,048 | 87.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 85 | 107 | $7,490 | $2,961 | 39.5% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 76 | 76 | $3,800 | $2,218 | 58.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 80 | 84 | $2,100 | $2,014 | 95.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 12 | 12 | $2,040 | $1,919 | 94.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 48 | 137 | $3,425 | $1,029 | 30.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 16 | 16 | $1,040 | $672.00 | 64.6% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 23 | 36 | $360.00 | $139.56 | 38.8% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 24 | 114 | $798.00 | $34.11 | 4.3% |
About Dr. Patrick Baquet, M.D
Dr. Patrick Baquet, M.D is a Family Medicine healthcare provider based in New Iberia, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326078577.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Baquet, M.D has received a total of $8,197 in payments from pharmaceutical and medical device companies, with $1,181 received in 2024. These payments were reported across 589 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($8,065).
As a Medicare-enrolled provider, Baquet has provided services to 3,000 Medicare beneficiaries, totaling 6,111 services with total Medicare billing of $208,346. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location New Iberia, LA
- Active Since 07/04/2006
- Last Updated 06/19/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1326078577
Products in Payments
- VRAYLAR (Drug) $1,105
- FARXIGA (Drug) $423.44
- UBRELVY (Drug) $314.64
- VYVANSE (Drug) $298.27
- JARDIANCE (Drug) $292.69
- Azstarys (Drug) $262.87
- XARELTO (Drug) $256.00
- JANUVIA (Drug) $199.55
- Prolia (Biological) $198.70
- BREZTRI (Drug) $166.03
- TRINTELLIX (Drug) $163.59
- ENTRESTO (Drug) $157.64
- QULIPTA (Drug) $154.15
- BYSTOLIC (Drug) $143.07
- Victoza (Drug) $140.10
- INVOKANA (Drug) $129.50
- CHANTIX (Drug) $123.69
- VIBERZI (Drug) $120.30
- QELBREE (Drug) $114.30
- Otezla (Drug) $112.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in New Iberia
Robert Lahasky, M.d.,, M.D.,
Family Medicine — Payments: $17,242
Angela Langlinais, Md, MD
Family Medicine — Payments: $17,040
Dr. Stephen Boudreaux, M.d, M.D
Family Medicine — Payments: $15,728
Jose Mata, Md, MD
Family Medicine — Payments: $15,309
George Cousin, Md, MD
Family Medicine — Payments: $13,712
Mrs. Michelle Menard, Md, MD
Family Medicine — Payments: $11,659